Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Egypt
Received date: April 10, 2017; Accepted date: April 24, 2017; Published date: April 29, 2017
Citation: El-Agamy A. Corneal Endothelium and Central Corneal Thickness Changes in Type 2 Diabetes Mellitus. Ins Ophthal. 2017, 1:2.
It is predicted that the number of diabetic patients will reach almost 552 million by the year 2030 . Type 2 diabetes mellitus (DM) represents 90% of cases and is characterized by overweight and insulin resistance . It is found that nearly 20% of patients identified by type 2 DM actually have type 1.5, or latent autoimmune DM who is a form of type 1 DM that affects adults with a slower course of onset compared to type 1 DM [2,3]. This special group of diabetic patients is not overweight and does not show insulin resistance .
All corneal layers are involved in DM in different ways such as corneal endothelial damage, recurrent corneal erosions, diminished corneal sensitivity, ulcers, delayed wound healing, and superficial keratitis [4-7]. Folds in Descemet's membrane were detected earlier in diabetic patients compared to non-diabetic elderly people [8-11].
Choo et al.  study documented morphological anomalies of corneal endothelium in type 2 diabetics such as a reduced endothelial cell density (ECD), polymorphism (decrease in the percentage of hexagonal cells), in addition to polymegathism (increased coefficient of variation (CV) of cell area (standard CV values are between 0.22 and 0.31 and beyond 0.4 is unusual).
Tripathy et al.  Choo et al.  and Browning  studies demonstrated that increased glucose levels induce augmented activity of the aldose reductase enzyme leading to sorbitol accumulation in the corneal epithelial and endothelial cells, which behaves as an osmotic agent producing swelling of corneal endothelium in diabetic cornea. Moreover, Na+ – K+ ATPase activity of the corneal endothelium in diabetics is decreased causing alterations of the corneal morphological and permeability features  In addition, diminished ATP manufacture caused by slowing down of the Krebs cycle disturbs endothelial pump function in diabetic cornea .
El-Agamy and Alsubaie , Sudhir et al. , Choo et al. , Inoue et al.  and Saini and Mittal  studies documented a significant reduction in ECD of diabetic corneas compared to controls. Conversely, Siribunkum et al.  study showed a significant increased corneal endothelial cell density in diabetic cornea. On the other hand, Storr-Paulsen et al.  confirmed that controlled type II DM has no influence on ECD.
Choo et al.  and Lee et al.  studies found a significant polymorphism in diabetic corneas compared to controls. Alternatively, El-Agamy and Alsubaie , Storr-Paulsen et al. , Sudhir et al.  and Inoue et al.  studies demonstrated no significant difference between the two groups.
Storr-Paulsen et al. , Su et al.  and Lee et al.  studies showed a significant increase in central corneal thickness (CCT) of diabetic cornea compared to controls. While El-Agamy and Alsubaie , Sudhir et al.  and Choo et al  studies did not show any significant difference between the two groups. Su et al.  and Busted et al.  studies proposed that increased CCT may be one of the earliest demonstrable alterations in diabetic eyes.
Regarding evaluation of the mean values of CCT, ECD, CV and cells hexagonality in patients with DM duration ≤ 10 years and those with DM duration >10 years: El-Agamy and Alsubaie  found no significant difference between the two groups. Also, Altay et al.  did not report any significant difference in CCT between the two groups. On the other hand, Lee et al.  found significantly higher CCT and CV in patients with DM duration >10 years than those with DM duration ≤ 10 years, without any significant difference regarding ECD and hexagonality between the two groups.
As regards assessment of the mean values of CCT, ECD, CV and cells hexagonality in diabetic patients with HbA1c ≤ 7.5% and those with HbA1c>7.5%: El-Agamy and Alsubaie  reported a significant difference only in CV between the two groups. However, Storr-Paulsen et al.  demonstrated lower ECD in patients with elevated HbA1c without any significant difference in CCT between the two groups. On the other hand, Altay et al.  found a significant increase in CCT in uncontrolled diabetics.
Shenoy et al.  and Saini and Mittal  found significantly lower ECD in eyes with diabetic retinopathy (DR) compared to those without DR. Moreover, Busted et al.  documented association of increased HbA1c and blood glucose levels, and severe retinal complications with increased CCT. Conversely, El- Agamy and Alsubaie  demonstrated no significant difference.
Some studies documented significant corneal changes in type 2 diabetic patients compared to non-diabetics whereas other studies did not find any significant differences between the two groups. Future studies with a large sample size and for long follow up duration will elucidate the scope of corneal insult caused by type 2 DM.
This research project was supported by a grant from the “Research Center of the Female Scientific and Medical Colleges”, Deanship of Scientific Research, King Saud University.